| Gene symbol | KLK3 | Synonyms | APS, KLK2A1, PSA, hK3 | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.33 | dbXrefs | |
| Description | kallikrein related peptidase 3 | ||||
| GTO ID | GTC1177 |
| Trial ID | NCT00006430 |
| Disease | Prostate Cancer |
| Altered gene | KLK3 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | mRNA vaccine |
| Treatment | dendritic cells transfected with amplified tumor RNA |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | A Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With Antigen Encoded in Amplified Autologous Tumor RNA |
| Year | 2000 |
| Country | United States |
| Company sponsor | National Center for Research Resources (NCRR) |
| Other ID(s) | NCRR-M01RR00030-0177|M01RR000030 |
| Vector information | |||
|
|||
| Cohort 1 | |||||
|
|||||